Products for Research Use Only
RegisterLogin

LX2931

CAT: 0804-HY-14370-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-14370-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LX2931 is an inhibitor of Sphingosine 1-Phosphate Lyase (S1PL) . LX2931 works by increasing levels of S1P inside and outside the cell. The decrease in S1PL activity leads to a significant increase in S1P content in tissues, especially in lymphoid tissues which may lead to a restricted exodus of lymphocytes from secondary immune tissues, resulting in lymphocytopenic and immunosuppressive effects in the peripheral circulation. LX2931 can be used in research for the treatment of autoimmune diseases, especially rheumatoid arthritis[1].
CAS Number
948840-25-3
UNSPSC
12352005
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Others
Assay Protocol
https://www.medchemexpress.com/lx2931.html
Purity
99.9
Solubility
DMSO : 100 mg/mL (ultrasonic; warming)
Smiles
OC[C@@H](O)[C@@H](O)[C@@H](C1=CN=C(/C(C)=N/O)N1)O
Molecular Formula
C9H15N3O5
Molecular Weight
245.23
References & Citations
[1]Bagdanoff J T, et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E) -1- (4- ((1 R, 2 S, 3 R) -1, 2, 3, 4-tetrahydroxybutyl) -1 H-imidazol-2-yl) ethanone oxime (LX2931) and (1 R, 2 S, 3 R) -1- (2- (isoxazol-3-yl) -1 H-imidazol-4-yl) butane-1, 2, 3, 4-tetraol (LX2932) [J]. Journal of medicinal chemistry, 2010, 53 (24) : 8650-8662.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-14371LX2932
HY-101122LX2761

Popular Products